Acute, but not Chronic, Exposure to Arsenic Provokes Glucose Intolerance in Rats: Possible Roles for Oxidative Stress and the Adrenergic Pathway

Matsukawa, 2015, Cyanidin-3-glucoside derived from black soybeans ameliorate type 2 diabetes through the induction of differentiation of preadipocytes into smaller and insulin-sensitive adipocytes, J Nutr Biochem, 26, 860, 10.1016/j.jnutbio.2015.03.006 Kulshrestha, 2014, Arsenic-induced abnormalities in glucose metabolism: Biochemical basis and potential therapeutic and nutritional interventions, World J Transl Med, 3, 96, 10.5528/wjtm.v3.i2.96 Shaw, 2010, Global estimates of the prevalence of diabetes for 2010 and 2030, Diabetes Res Clin Pract, 87, 4, 10.1016/j.diabres.2009.10.007 World Health Organization, 2009 Zhu, 2015, Mortality rates and the causes of death related to diabetes mellitus in Shanghai Songjiang District: an 11-year retrospective analysis of death certificates, BMC Endocrine Disorders, 15, 45, 10.1186/s12902-015-0042-1 Golozar, 2011, Diabetes mellitus and its correlates in an Iranian adult population, PLoS ONE, 6, 10.1371/journal.pone.0026725 Hu, 2001, Diet, lifestyle, and the risk of type 2 diabetes mellitus in women, N Engl J Med, 345, 790, 10.1056/NEJMoa010492 Zimmet, 2001, Global and societal implications of the diabetes epidemic, Nature, 414, 782, 10.1038/414782a Lai, 1994, Ingested inorganic arsenic and prevalence of diabetes mellitus, Am J Epidemiol, 139, 484, 10.1093/oxfordjournals.aje.a117031 Nizam, 2013, Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh, Int J Environ Res Public Health, 10, 1006, 10.3390/ijerph10031006 Rahman, 1996, Diabetes mellitus among Swedish art glass workers: An effect of arsenic exposure?, Scand J Work Environ Health, 146, 10.5271/sjweh.123 Wang, 2003, Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan, Environ Health Perspect, 111, 155, 10.1289/ehp.5457 Tseng, 2000, Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan, Environ Health Perspect, 108, 847, 10.1289/ehp.00108847 Tseng, 2002, Epidemiologic evidence of diabetogenic effect of arsenic, Toxicol Lett, 133, 69, 10.1016/S0378-4274(02)00085-1 Rahman, 1998, Diabetes mellitus associated with arsenic exposure in Bangladesh, Am J Epidemiol, 148, 198, 10.1093/oxfordjournals.aje.a009624 Rahman, 1995, Diabetes mellitus and arsenic exposure: A second look at case-control data from a Swedish copper smelter, Occup Environ Med, 52, 773, 10.1136/oem.52.11.773 Rahman, 1999, Relations between exposure to arsenic, skin lesions, and glucosuria, Occup Environ Med, 56, 277, 10.1136/oem.56.4.277 Wang, 2007, Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan, Environ Int, 33, 805, 10.1016/j.envint.2007.03.004 Boyd, 2005, Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance, JAMA, 294, 716, 10.1001/jama.294.6.716 Flora, 1999, Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2, 3–dimercaptosuccinic acid in rats, Clin Exp Pharmacol Physiol, 26, 865, 10.1046/j.1440-1681.1999.03157.x Kannan, 2004, Chronic arsenic poisoning in the rat: Treatment with combined administration of succimers and an antioxidant, Ecotoxicol Environ Saf, 58, 37, 10.1016/S0147-6513(03)00096-4 Kumagai, 2007, Arsenic: Signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity, Annu Rev Pharmacol Toxicol, 47, 243, 10.1146/annurev.pharmtox.47.120505.105144 Shi, 2004, Oxidative mechanism of arsenic toxicity and carcinogenesis, Mol Cell Biochem, 255, 67, 10.1023/B:MCBI.0000007262.26044.e8 Yamanaka, 1994, Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals, Environ Health Perspect, 102, 37, 10.1289/ehp.94102s337 Cohen, 2002, Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat, Chem Res Toxicol, 15, 1150, 10.1021/tx020026z Petrick, 2000, Monomethylarsonous acid MMA III. is more toxic than arsenite in Chang human hepatocytes, Toxicol Appl Pharmacol, 163, 203, 10.1006/taap.1999.8872 Andrewes, 2003, Dimethylarsine and trimethylarsine are potent genotoxins in vitro, Chem Res Toxicol, 16, 994, 10.1021/tx034063h Nesnow, 2002, DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species, Chem Res Toxicol, 15, 1627, 10.1021/tx025598y Stýblo, 2002, The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update, Environ Health Perspect, 110, 767, 10.1289/ehp.02110s5767 Pal, 2004, Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate, Drug Chem Toxicol, 27, 179, 10.1081/DCT-120037501 Flora, 2007, Arsenic-induced oxidative stress and the role of antioxidant supplementation during chelation: A review, J Environ Biol, 28, 333 Banner, 1986, Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds, Toxicol Appl Pharmacol, 83, 142, 10.1016/0041-008X(86)90331-5 Franklin, 2002, Epidermal growth factor receptor family in lung cancer and premalignancy, Semin Oncol, 29, 3, 10.1053/sonc.2002.31520 Modi, 2006, Co-administration of zinc and N-acetylcysteine prevents arsenic-induced tissue oxidative stress in male rats, J Trace Elem Med Biol, 20, 197, 10.1016/j.jtemb.2006.02.002 Flora, 2009, Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure, Oxid Med Cell Longev, 2, 191, 10.4161/oxim.2.4.9112 Patrick, 2003, Toxic metals and antioxidants, Part II. The role of antioxidants in arsenic and cadmium toxicity, Altern Med Rev, 8, 106 Hemalatha, 2013, Evaluation of protective effect of N-acetyl cysteine on arsenic-induced hepatotoxicity, J Nat Sci Biol Med, 4, 393, 10.4103/0976-9668.116986 Young, 2009, Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats, Psychopharmacology (Berl), 203, 369, 10.1007/s00213-008-1317-2 Ghafghazi, 1980, The effects of acute and subacute sodium arsenite administration on carbohydrate metabolism, Toxicol Appl Pharmacol, 55, 126, 10.1016/0041-008X(80)90228-8 Mejia, 1997, Effects of lead-arsenic combined exposure on central monoaminergic systems, Neurotoxicol Teratol, 19, 489, 10.1016/S0892-0362(97)00066-4 Rodrıguez, 2001, The effects of sodium arsenite exposure on behavioral parameters in the rat, Brain Res Bull, 55, 301, 10.1016/S0361-9230(01)00477-4 Lin, 2007, Endoplasmic reticulum stress is involved in arsenite-induced oxidative injury in rat brain, Toxicol Appl Pharmacol, 224, 138, 10.1016/j.taap.2007.06.016 Valkonen, 1983, Arsenic distribution and neurochemical effects in peroral sodium arsenite exposure of rats, Bull Environ Contam Toxicol, 30, 303, 10.1007/BF01610137 Kobayashi, 1987, Effects of arsenic on cholinergic parameters in brain in vitro, Neuropharmacology, 26, 1707, 10.1016/0028-3908(87)90121-3 Nagaraja, 1993, Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats, Bull Environ Contam Toxicol, 50, 100, 10.1007/BF00196547 Longnecker, 2001, Environmental contaminants as etiologic factors for diabetes, Environ Health Perspect, 109, 871, 10.1289/ehp.01109s6871 Maull, 2012, Evaluation of the association between arsenic and diabetes: A National Toxicology Program workshop review, Environ Health Perspect, 120, 1658, 10.1289/ehp.1104579 Kumar, 2013, Withania somnifera protects the haematological alterations caused by sodium arsenite in Charles foster rats, Int J Res Ayurveda Phar, 4 Delnomdedieu, 1994, Reduction and binding of arsenate and dimethylarsinate by glutathione: A magnetic resonance study, Chem Biol Interact, 90, 139, 10.1016/0009-2797(94)90099-X Villa-Lojo, 2002, Coupled high performance liquid chromatography-microwave digestion-hydride generation: Atomic absorption spectrometry for inorganic and organic arsenic speciation in fish tissue, Talanta, 57, 741, 10.1016/S0039-9140(02)00094-2 Bazuine, 2003, Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity, Eur J Biochem, 270, 3891, 10.1046/j.1432-1033.2003.03771.x Flora, 2011, Arsenic-induced oxidative stress and its reversibility, Free Radic Biol Med, 51, 257, 10.1016/j.freeradbiomed.2011.04.008 Navas-Acien, 2006, Arsenic exposure and type 2 diabetes: A systematic review of the experimental and epidemiologic evidence, Environ Health Perspect, 641, 10.1289/ehp.8551 Rana, 2014, Perspectives in endocrine toxicity of heavy metals, Biol Trace Elem Res, 160, 1, 10.1007/s12011-014-0023-7 Goggin, 2012, Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice, Neurotoxicology, 33, 1338, 10.1016/j.neuro.2012.08.010 Hunt, 2002, Propranolol prevents epinephrine from limiting insulin-stimulated muscle glucose uptake during contraction, J Appl Physiol, 93, 697, 10.1152/japplphysiol.00017.2002 Kumar, 2011, Neuroprotective effect of carvedilol against aluminium induced toxicity: Possible behavioral and biochemical alterations in rats, Pharmacol Rep, 63, 915, 10.1016/S1734-1140(11)70607-7 Chang, 2012, Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus, Acta Diabetol, 49, S171, 10.1007/s00592-012-0398-x Torimoto, 2013, Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus, Cardiovasc Diabetol, 12, 1, 10.1186/1475-2840-12-1